|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Braidwell LP
✚
|
|
|---|---|
| CRD # | 316988 |
| SEC # | 801-122966 |
| CIK # | 0001920938 |
| AUM | $5.2 B (2025-03-31) |
| Employees | 38 (53% Investors, 0% Brokers) |
| Phone | 866-453-3929 |
| Address | One Harbor Point, 2200 Atlantic Street Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Neurocrine Biosciences Inc | 0.1 | ||
| Xenon Pharmaceuticals Inc | 0.1 | ||
| Argenx SE | 0.1 | ||
| Krystal Biotech Inc | 0.1 | ||
| Align Technology Inc | 0.1 | ||
| Legend Biotech Corp | 0.1 | ||
| Nuvalent Inc | 0.1 | ||
| CG Oncology Inc | 0.1 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| Inspire Medical Systems Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Braidwell Companion CMV 2024-1 LP | 2024-11-26 | 4.9 | |
| HF | Braidwell Companion CMV 2024-1 Master Fund LP | 2024-11-26 | 5.5 | |
| HF | Braidwell Companion CMV Transaction Mater Fund LP - 2024-1 Series | 2024-11-26 | 3.1 | |
| HF | Braidwell Companion CMV US LP - 2024-1 Series | 2024-11-26 | 6.6 | |
| HF | Braidwell Companion CMV LP | [2021-12-01] | 66.5 | 5.3 |
| HF | Braidwell Companion CMV Master Fund LP | 2021-12-01 | 0.2 | |
| HF | Braidwell Companion CMV Transaction Master Fund LP - 2023-1 Series | 2021-12-01 | 14.0 | |
| HF | Braidwell Companion CMV US LP - 2023-1 Series | [2021-12-01] | 63.4 | 8.9 |
| HF | Braidwell Partners LP | [2021-12-01] | 2,808.9 | 2,360.7 |
| HF | Braidwell Partners Master Fund LP | 2021-12-01 | 2,899.6 | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 5.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 12 | 5.2 |
| By Discretionary | ||
| Discretionary | 12 | 5.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 12 | 5.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.9 | |
| United States Persons | 2.3 | |
| Total | 12 | 5.2 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Braidwell LP | 6 | ||
| Manish Mital | 6 | ||
| Braidwell GP LLC | 6 | ||
| Brian Kreiter | 6 | ||
| Alexander Karnal | 5 | ||
| Colin Bettison | 2 | ||
| Alexander Karal | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001920938] | |
| SC 13G | [0001920938] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Braidwell LP | DBV Technologies Sa | [2023-02-14] |
| Braidwell LP | Crinetics Pharmaceuticals Inc | [2023-02-14] |
| Braidwell LP | Deciphera Pharmaceuticals Inc | [2023-02-14] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Complus Asset Management Limited
✚
|
5.4 | |
|
Complus Asset Management Singapore PTE Ltd
✚
|
5.4 | |
|
Caledonia US LP
✚
|
NY | 5.3 |
|
PAAMCO Prisma LLC
✚
|
CA | 5.2 |
|
Deep Track Capital LP
✚
|
CT | 5.2 |
|
Candlestick Capital Management LP
✚
|
CT | 5.2 |
|
Hennessy Advisors Inc
✚
|
CA | 5.1 |
|
HFR Investments LLC
✚
|
IL | 5.1 |
|
HFR Asset Management LLC
✚
|
IL | 5.1 |
|
Skye Global Management LP
✚
|
FL | 5.1 |